Sonpavde G - Search Results

1

Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate Cancer.

Ledet EM, Lilly MB, Sonpavde G, Lin E, Nussenzveig RH, Barata PC, Yandell M, Nagy RJ, Kiedrowski L, Agarwal N, Sartor O. Ledet EM, et al. Among authors: sonpavde g. Oncologist. 2020 Apr;25(4):327-333. doi: 10.1634/theoncologist.2019-0115. Epub 2019 Nov 11. Oncologist. 2020. PMID: 32297439 Free PMC article.

2

Abiraterone acetate: a promising drug for the treatment of castration-resistant prostate cancer.

Agarwal N, Hutson TE, Vogelzang NJ, Sonpavde G. Agarwal N, et al. Among authors: sonpavde g. Future Oncol. 2010 May;6(5):665-79. doi: 10.2217/fon.10.48. Future Oncol. 2010. PMID: 20465382 Review.

3

Cabazitaxel for the treatment of castration-resistant prostate cancer.

Agarwal N, Sonpavde G, Sartor O. Agarwal N, et al. Among authors: sonpavde g. Future Oncol. 2011 Jan;7(1):15-24. doi: 10.2217/fon.10.168. Future Oncol. 2011. PMID: 21174534

4

Recent advances in immunotherapy for the treatment of prostate cancer.

Sonpavde G, Agarwal N, Choueiri TK, Kantoff PW. Sonpavde G, et al. Expert Opin Biol Ther. 2011 Aug;11(8):997-1009. doi: 10.1517/14712598.2011.575357. Epub 2011 Jun 15. Expert Opin Biol Ther. 2011. PMID: 21675925 Review.

5

Novel molecular targets for the therapy of castration-resistant prostate cancer.

Agarwal N, Sonpavde G, Sternberg CN. Agarwal N, et al. Among authors: sonpavde g. Eur Urol. 2012 May;61(5):950-60. doi: 10.1016/j.eururo.2011.12.028. Epub 2011 Dec 22. Eur Urol. 2012. PMID: 22209376 Review.

6

Pooled analysis of phase II trials evaluating weekly or conventional cisplatin as first-line therapy for advanced urothelial carcinoma.

Maughan BL, Agarwal N, Hussain SA, Boucher KM, Von Der Maase H, Kaufman DS, Lorusso V, Moore MJ, Galsky MD, Sonpavde G. Maughan BL, et al. Among authors: sonpavde g. Clin Genitourin Cancer. 2013 Sep;11(3):316-20. doi: 10.1016/j.clgc.2012.12.007. Epub 2013 Jan 16. Clin Genitourin Cancer. 2013. PMID: 23332638 Clinical Trial.

7

Management of castrate resistant prostate cancer-recent advances and optimal sequence of treatments.

Zhang TY, Agarwal N, Sonpavde G, DiLorenzo G, Bellmunt J, Vogelzang NJ. Zhang TY, et al. Among authors: sonpavde g. Curr Urol Rep. 2013 Jun;14(3):174-83. doi: 10.1007/s11934-013-0322-0. Curr Urol Rep. 2013. PMID: 23559076

8

New agents for prostate cancer.

Agarwal N, Di Lorenzo G, Sonpavde G, Bellmunt J. Agarwal N, et al. Among authors: sonpavde g. Ann Oncol. 2014 Sep;25(9):1700-1709. doi: 10.1093/annonc/mdu038. Epub 2014 Mar 20. Ann Oncol. 2014. PMID: 24658665 Free article. Review.

9

Incidence of Severe Nephrotoxicity With Cisplatin Based on Renal Function Eligibility Criteria: Indirect Comparison Meta-analysis.

Dahal A, Bellows BK, Sonpavde G, Tantravahi SK, Choueiri TK, Galsky MD, Agarwal N. Dahal A, et al. Among authors: sonpavde g. Am J Clin Oncol. 2016 Oct;39(5):497-506. doi: 10.1097/COC.0000000000000081. Am J Clin Oncol. 2016. PMID: 24824144 Review.

10

Cisplatin-based first-line therapy for advanced urothelial carcinoma after previous perioperative cisplatin-based therapy.

Necchi A, Pond GR, Giannatempo P, Di Lorenzo G, Eigl BJ, Locke J, Pal SK, Agarwal N, Poole A, Vaishampayan UN, Niegisch G, Hussain SA, Singh P, Bellmunt J, Sonpavde G. Necchi A, et al. Among authors: sonpavde g. Clin Genitourin Cancer. 2015 Apr;13(2):178-84. doi: 10.1016/j.clgc.2014.08.010. Epub 2014 Sep 23. Clin Genitourin Cancer. 2015. PMID: 25450035 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

507 results

Search Page

Filters